Moreover, we showed that anti-Fn-IgA and anti-Fn-IgG were significantly elevated in early stage CRC compared with normal controls or those with benign disease, but only slightly elevated when compared early stage CRC to advanced CRC. Here, CD79A is linked to colorectal carcinoma.